【南华生物(000504.SZ)预计2021年度由盈转亏 归母净亏1350万元–1650万元】智通财经APP讯，南华生物(000504.SZ)发布公告，预计公司2021年度归属于上市公司股东的净亏损1,350万元–1,650万元，同比由盈转亏。扣除非经常性损益后的净亏损2,150万元–2,450万元，同比由盈转亏。基本每股亏损0.04元/股–0.05元/股。

【南华生物(000504.SZ)预计2021年度由盈转亏 归母净亏1350万元–1650万元】智通财经APP讯，南华生物(000504.SZ)发布公告，预计公司2021年度归属于上市公司股东的净亏损1,350万元–1,650万元，同比由盈转亏。扣除非经常性损益后的净亏损2,150万元–2,450万元，同比由盈转亏。基本每股亏损0.04元/股–0.05元/股。

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.